Mid-American Wealth Advisory Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Mid-American Wealth Advisory Group’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-20	Closed	-$1.66K	–	334
2025 Q2	$1.66K	Buy	+20	New	+$1.6K	﹤0.01%	273

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Mid-American Wealth Advisory Group's XBI Position: Q3 2025 in Review

Mid-American Wealth Advisory Group sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2025, closing a stake of 20 shares — an estimated $1.66K sold.

Mid-American Wealth Advisory Group first reported a position in XBI in Q2 2025 and held it in 1 quarter. The position peaked at $1.66K in Q2 2025. 656 funds tracked by Wall St. Rank hold XBI as of Q3 2025.

Mid-American Wealth Advisory Group reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2025 after selling out during the quarter.
Mid-American Wealth Advisory Group sold 20 State Street SPDR S&P Biotech ETF shares in Q3 2025, an estimated $1.66K.
Mid-American Wealth Advisory Group first reported a position in State Street SPDR S&P Biotech ETF in Q2 2025 and held it in 1 quarter.
Mid-American Wealth Advisory Group's State Street SPDR S&P Biotech ETF position peaked at $1.66K in Q2 2025.
656 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2025.

Based on Mid-American Wealth Advisory Group's 13F filing for Q3 2025, filed 20 Oct 2025.